Maternal serum vitamin D levels and preeclampsia among Kenyan pregnant women: A matched case-control study
5 affiliations
- 1Department of Obstetrics and Gynaecology, The Nairobi Hospital, Nairobi, Kenya
- 2Department of Reproductive Health, Moi University, College of Health Sciences (MUCHS), Eldoret, Kenya
- 3Department of Psychology, Eldoret Oncology Associates, Eldoret, Kenya
- 4Department of Medical Oncology, Eldoret Oncology Associates, Eldoret, Kenya
- 5Nuffield Department of Women's & Reproductive Health, University of Oxford, Level 3 Women's Centre, John Radcliffe Hospital, Oxford, United Kingdom
Abstract
Background: Preeclampsia accounts for about one in five direct maternal deaths in Kenya. Low vitamin D levels have been linked to its pathophysiology. Despite this, context‑specific data from African populations remain limited. The study aimed to determine the association between maternal serum 25-hydroxyvitamin D [25(OH)D] concentrations (nmol/L) in pregnancy and the risk of preeclampsia in a Kenyan population. Methods: A matched case-control study was conducted at Moi Teaching and Referral Hospital, Kenya. A total of 118 women with confirmed viable intrauterine pregnancies at ≥28 weeks’ gestation were analysed. Fifty-nine women with preeclampsia (cases) and 59 controls were matched by parity, gestation, and age. Serum 25(OH)D was quantified. Vitamin D status was categorised as suboptimal (<50 nmol/L) or sufficient (≥50 nmol/L) status. The association between vitamin D status and preeclampsia was assessed using conditional logistic regression. Odds ratios (ORs) with 95% confidence intervals (CIs) were presented. Results: Median serum 25(OH)D was significantly lower in preeclampsia cases compared with controls [67.1 nmol/L (interquartile range 47.8–84.0) vs. 77.6 nmol/L (62.4–99.7); P = 0.001]. Suboptimal vitamin D levels (<50 nmol/L) were observed in 32.2% of preeclampsia cases versus 6.8% of controls (P = 0.002). In conditional logistic regression accounting for matching, women with suboptimal vitamin D had higher odds of preeclampsia (OR 8.0; 95% CI: 1.84–34.78; P = 0.006). Each 10 nmol/L decrease in serum 25(OH)D was associated with a 29% increase in preeclampsia odds (OR 1.29; 95% CI: 1.09–1.54; P = 0.004). Conclusions: In this study, suboptimal maternal serum vitamin D status demonstrated a significant association with preeclampsia. There is potential value in antenatal screening for vitamin D status. Findings support further research into vitamin D supplementation as a preventive intervention for preeclampsia. Trial registration: Pan African Clinical Trial Registry (PACTR202505516303679).
Related
- Derived inflammatory indicators for identifying preeclampsia in pregnant patients with systemic lupus erythematosus: a case–control study
- Predictors of Preeclampsia and Pregnancy Associated Outcomes Among Pregnant Women: A Prospective Cohort Study in Selected Hospitals in Kiambu County, Kenya
- Maternal cell-free RNA versus combined screening for first-trimester prediction of early-onset preeclampsia: a nested case-control study
- Maternal exposure to PM2.5 and its components and risk of small for gestational age in women undergoing in vitro fertilization: a propensity score-matched case-control study in Guangzhou, China.
- Maternal serum retinol, vitamin K, and ferritin profiles during pregnancy, gestational diabetes mellitus, and offspring neurodevelopment: a prospective case-control study
BibTeX
@article{omwodo2026maternal,
title = {{Maternal serum vitamin D levels and preeclampsia among Kenyan pregnant women: A matched case-control study}},
author = {Kimbley Asaso Omwodo and Joy Njoki Kimani and Kuboi Nicodemus and David Mbugua Kioko and Antoniya Georgieva},
journal = {PLOS One},
year = {2026},
month = sep,
doi = {10.1371/journal.pone.0358781},
url = {https://doi.org/10.1371/journal.pone.0358781},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Maternal serum vitamin D levels and preeclampsia among Kenyan pregnant women: A matched case-control study
AU - Kimbley Asaso Omwodo
AU - Joy Njoki Kimani
AU - Kuboi Nicodemus
AU - David Mbugua Kioko
AU - Antoniya Georgieva
PY - 2026
DA - 2026/09/22
JO - PLOS One
DO - 10.1371/journal.pone.0358781
UR - https://doi.org/10.1371/journal.pone.0358781
AB - Background: Preeclampsia accounts for about one in five direct maternal deaths in Kenya. Low vitamin D levels have been linked to its pathophysiology. Despite this, context‑specific data from African populations remain limited. The study aimed to determine the association between maternal serum 25-hydroxyvitamin D [25(OH)D] concentrations (nmol/L) in pregnancy and the risk of preeclampsia in a Kenyan population. Methods: A matched case-control study was conducted at Moi Teaching and Referral Hospital, Kenya. A total of 118 women with confirmed viable intrauterine pregnancies at ≥28 weeks’ gestation were analysed. Fifty-nine women with preeclampsia (cases) and 59 controls were matched by parity, gestation, and age. Serum 25(OH)D was quantified. Vitamin D status was categorised as suboptimal (<50 nmol/L) or sufficient (≥50 nmol/L) status. The association between vitamin D status and preeclampsia was assessed using conditional logistic regression. Odds ratios (ORs) with 95% confidence intervals (CIs) were presented. Results: Median serum 25(OH)D was significantly lower in preeclampsia cases compared with controls [67.1 nmol/L (interquartile range 47.8–84.0) vs. 77.6 nmol/L (62.4–99.7); P = 0.001]. Suboptimal vitamin D levels (<50 nmol/L) were observed in 32.2% of preeclampsia cases versus 6.8% of controls (P = 0.002). In conditional logistic regression accounting for matching, women with suboptimal vitamin D had higher odds of preeclampsia (OR 8.0; 95% CI: 1.84–34.78; P = 0.006). Each 10 nmol/L decrease in serum 25(OH)D was associated with a 29% increase in preeclampsia odds (OR 1.29; 95% CI: 1.09–1.54; P = 0.004). Conclusions: In this study, suboptimal maternal serum vitamin D status demonstrated a significant association with preeclampsia. There is potential value in antenatal screening for vitamin D status. Findings support further research into vitamin D supplementation as a preventive intervention for preeclampsia. Trial registration: Pan African Clinical Trial Registry (PACTR202505516303679).
SN - 1932-6203
ER -